Alector logo
Alector ALEC
$ 1.44 -1.03%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Alector Historical Prices 2011-2025 | ALEC

Annual Historical Prices Alector

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.69 7.02 8.56 15.9 16.8 27.9 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
27.9 1.69 13

Historical Prices of other stocks in the Biotechnology industry

Issuer Historical Prices Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
18.2 - 2.43 % $ 254 M germanyGermany
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
2.68 $ 4.78 -0.31 % $ 793 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
1.97 $ 3.03 -0.49 % $ 234 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12 - - $ 1.01 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.04 - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
9.78 - 4.14 % $ 49.1 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
0.75 $ 1.15 -1.71 % $ 6.27 M chinaChina
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
0.82 - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
0.57 - - $ 10.1 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
0.29 - -18.52 % $ 27.3 M britainBritain
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
153 $ 209.39 -1.61 % $ 5 B danmarkDanmark
Aptevo Therapeutics Aptevo Therapeutics
APVO
3.22 $ 0.6 -35.8 % $ 166 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
0.58 $ 3.12 0.81 % $ 7.51 B australiaAustralia
Biophytis SA Biophytis SA
BPTS
0.33 - -13.47 % $ 169 M franceFrance
BioVie BioVie
BIVI
1.65 $ 1.2 -5.51 % $ 1.77 M usaUSA
Athersys Athersys
ATHX
0.9 - 3.77 % $ 22.4 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
0.42 - -52.27 % $ 4.45 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
28.8 - 1052.0 % $ 415 M usaUSA
AVROBIO AVROBIO
AVRO
1.27 - 1083.1 % $ 745 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
1.45 $ 0.22 24.46 % $ 479 M israelIsrael
Acasti Pharma Acasti Pharma
ACST
3.37 - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
1.7 - -15.15 % $ 60.3 M britainBritain
BioDelivery Sciences International BioDelivery Sciences International
BDSI
3.1 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
28.5 - -0.23 % $ 916 M usaUSA
BioNTech SE BioNTech SE
BNTX
95.4 $ 94.72 -0.33 % $ 27.2 B germanyGermany
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
27 $ 27.09 1.04 % $ 1.31 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
185 - 0.49 % $ 251 B cayman-islandsCayman-islands
Anika Therapeutics Anika Therapeutics
ANIK
25.4 $ 9.6 1.27 % $ 141 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
0.27 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
1.7 - -7.31 % $ 87 M usaUSA
bluebird bio bluebird bio
BLUE
0.61 - - $ 546 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
92.9 - -6.81 % $ 3.04 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
0.77 - 2.71 % $ 14 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
13.3 - -10.95 % $ 876 K usaUSA
Axon Enterprise Axon Enterprise
AXON
526 $ 584.81 -1.07 % $ 44.3 B usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
3.64 $ 2.53 -8.33 % $ 30.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
0.5 - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
2.51 $ 2.44 -3.56 % $ 15.3 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
74.2 $ 92.79 0.37 % $ 96.9 B britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
13.5 - -24.86 % $ 820 K usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
0.51 $ 12.33 -0.29 % $ 812 M usaUSA
Brickell Biotech Brickell Biotech
BBI
2.11 - -5.38 % $ 6.06 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
10.6 $ 9.1 1.0 % $ 1.48 B britainBritain
Celldex Therapeutics Celldex Therapeutics
CLDX
20.4 $ 26.29 -2.01 % $ 1.69 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
133 $ 11.07 2.45 % $ 716 M usaUSA
Biogen Biogen
BIIB
133 $ 176.45 0.07 % $ 25.7 B usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
41.2 - - $ 7.29 B usaUSA